CSI Market
Sign In | Register

Bioventus Inc (BVS) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access BVS Annual Income Statement →
This income statement overview for Bioventus Inc spans from Sep 27 2025 to Sep 26 2026, showing how the company's revenues, expenses, and earnings have changed across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 26 2026)
Q3 2026 		(Jun 27 2026) (Mar 28 2026) (Dec 31 2025) (Sep 27 2025)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax142.44
Total Revenue142.44
Costs & Expenses
Cost of Goods and Services Sold45.31
Gross Profit97.13
Selling, Administration, Marketing82.95
Depreciation & Amortization1.05
Research and Development Expense3.44
Restructuring Charges0.00
Other Operating Expense / -Income-4.76
Total operating costs including COS132.74
Operating income / -loss9.70
Interest Expense0.00
Net Interest (-)Expense / Income-3.76
Extinguishment of Debt0.00
Foreign Currency Transaction (Gain) Loss0.00
Other loss / -income0.00
Total costs & expenses136.28
Income & Taxes
Income / -loss before income taxes6.16
Income taxes expenses / -benefit-0.70
Income after income taxes6.86
Net income / -loss of other equity-0.87
Income / -loss from continuing operations5.99
Non-controlling interests0.87
Other0.00
Net income / -loss5.99
Income / -loss to shareholder5.12
EBIT9.92
EBITD21.28
EBITDA21.28
Earnings Per Share
Basic EPS (excl. extra items)0.09
Basic Net EPS0.09
Basic shares outstanding (Mill. of Units)68.38
Diluted Net EPS0.08
Diluted average shares (Mill. of Units)72.49
4 historic quarters locked

Sign in to unlock the full Bioventus Inc income statement history.

Sign In Create Free Account

About Bioventus Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: November 2, 2026
  • Original filing: bvs-20260926.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI